Increased cellular senescence: The enemy within the body.
Chronic disease may be driven in part by increasing metabolic damage associated with a growing population of senescent cells. Senescent cells are damaged cells that the immune system must remove and replace with new cells generated by that organ's stem cells to maintain metabolic efficiency.
A damaged cell signals its removal by generating pro-inflammatory signals known as the Senescence-Associated Secretory Phenotype (SASP), alerting the immune system to clear it. This is critical for successful wound healing and suppression of tumor growth.
However, as the immune system ages, it becomes less responsive to these inflammatory signals, and it fails to remove damaged cells. This is known as inflammaging. The SASP can then begin to negatively affect nearby cells, damaging them and generating new senescent cells. This is why senescent cells are often referred to as “zombie cells”.
A growing population of senescent cells in an organ causes ongoing inflammatory damage, reduces metabolic function, accelerates the earlier development of chronic disease, and increases the rate of aging.
Cellular senescence is a two-edged sword. It is essential for wound healing and tumor suppression as it signals the immune system to remove damaged cells. A damaged cell alerts the immune system by sending inflammatory signals (i.e., SASP) that recruit immune cells to remove it and then stimulate stem cells to replace it with a new functional cell.
However, as we age, our immune system becomes less efficient at recognizing those inflammatory signals. This is known as inflammaging. The result is a growing population of damaged senescent cells that becomes a major internal source of chronic low-grade inflammation that drives chronic disease and accelerates aging.
Cellular senescence is complex, so here are some general references that can provide a better introduction to its implications in chronic disease development (1-7).
Complex metabolic pathways control the removal of damaged senescent cells and the repair of that tissue using new cells generated from stem cells. This can’t be done with drugs, but it can be accomplished using Metabolic Engineering®.
General References on Cellular Senescence
- von Kobbe C. Targeting senescent cells: Approaches, opportunities, challenges. Aging (Albany NY). 2019 11:12844-12861 (2019). doi: 10.18632/aging.102557.
- Zhang L, et al. Cellular senescence: A key therapeutic target in aging and diseases. J Clin Invest. 132:e158450 (2022). doi: 10.1172/JCI158450.
- Chmielewski PP. Cellular senescence and inflammageing: From mechanisms to senotherapeutic interventions. Biogerontology. 27:129 (2026). doi: 10.1007/s10522-026-10477-2.
- Shakur E et al. Escape and evasion: When immunosurveillance of senescent cells goes wrong. Front Genet. 17:1882818 (2026). doi: 10.3389/fgene.2026.1882818.
- Spinelli R et al. Increased cell senescence in human metabolic disorders. J Clin Invest. 133:e169922 (2023). doi: 10.1172/JCI169922.
- Wiley CD, Campisi J. The metabolic roots of senescence: Mechanisms and opportunities for intervention. Nat Metab. 3:1290-1301 (2021). doi: 10.1038/s42255-021-00483-8.
- Kuehnemann C, Wiley CD. Senescent cells at the crossroads of aging, disease, and tissue homeostasis. Aging Cell. 23:e13988 (2024). doi: 10.1111/acel.13988.